Please ensure Javascript is enabled for purposes of website accessibility
ホーム > 製品 > 抗体 > バイオシミラー

Anti-Ticagrelor Reference Antibody (Bentracimab, RUO) (YP489016)

Anti-Ticagrelor Reference Antibody (Bentracimab, RUO)
Anti-Ticagrelor Reference Antibody (Bentracimab, RUO)
価格(USD):
スペック:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
数量:
お問い合わせ
  • 概要

  • イメージ

  • 参考文献

  • データシート

  • SDS

概要
カタログ番号YP489016
説明
Bentracimab (YP489016) is a research-grade recombinant antibody targeting Ticagrelor. Produced in mammalian cells with native-like glycosylation.
Highlights
  • ●Research Grade — For PK/PD studies, assay development, and ADA research.
  • ●Native Glycosylation — Mammalian expression ensures native-like patterns.
種反応性General
アプリケーションELISA, Bioactivity: FACS, Functional assay, Research in vivo
宿主種Human
クローン性Monoclonal
アイソタイプFab-G1-lambda
クローンIDBentracimab
発現システム Mammalian cells
ターゲット Ticagrelor
エンドトキシンレベル < 10 EU/mg
純度 >95% purity as determined by SDS-PAGE.
精製 Protein A/G purified from cell culture supernatant.
アクセッション番号 CAS: 274693-27-5
形態 Liquid
保存バッファー 0.01M PBS pH 7.4

データシートのハードコピーまたはロット固有のCOAに記載された具体的なバッファー情報を参照してください。

製品使用情報
アプリケーション 希釈
ELISA 1:2000-1:20000
安定性と保存 Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
別名MEDI2452, anti-ticagrelor, antidote for ticagrelor, CAS: 274693-27-5
背景Bentracimab (PB 2452) is a neutralizing monoclonal antibody that binds Ticagrelor and its major active circulating metabolite with high affinity. Bentracimab can rapidly reverse the antiplatelet effect of Ticagrelor.
• Ticagrelor., PMID:35396017
• Ticagrelor with or without Aspirin in High-Risk Patients after PCI., PMID:31556978
• Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Systematic Review and Patient-Level Meta-Analysis., PMID:38506796
• Ticagrelor: clinical development and future potential., PMID:34258905
• Ticagrelor resistance: a case series and algorithm for management of non-responders., PMID:34215660
• Is ticagrelor worth its high cost and side-effects?, PMID:29730968
• Ticagrelor in stable coronary disease., PMID:37586825
• Ticagrelor-Associated Urticaria., PMID:35639409
• Ticagrelor Use in Stroke Patients: Past, Present, and Future., PMID:34163168
• Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial., PMID:32334703
注意事項 For research use only. Not suitable for clinical or therapeutic use.
イメージ
  • Anti-Ticagrelor Reference Antibody (Bentracimab, RUO)

    SDS-PAGE

    SDS-PAGE for Research Grade Bentracimab

参考文献
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
レコメンデーション

お問い合わせ カスタムクォート、大量リクエストおよびその他の問題については

メール: [email protected]

ディストリビューターリスト